reason

dilution

Baudax Bio Inc

crash

$BXRX This is like a bloody car crash - I cannot look away.

flow

Money flow now &quot;extreme bearish.&quot;

management

BXRX management and BOD are the definition of FAILURE!!

$BXRX Watching all the new bulls here compared to a month ago, some of you will end up bag holding this for a long time.. this company has some of the most selfish management in the entire market.

This can only be due to fraudulent practices on the part of Baudax Bio management, such as misrepresenting the market potential of Anjeso, lying about the CEO&#39;s credentials, colluding with short sellers, etc.

i’ve watched it for years.. nothing good ever happens with management

Stay far, far away from this toxic stock, company and management.

but that this  company is allowed to continue to serve as an ATM for management, while fleecing investors, is an absolute travesty.

BXRX management should be in jail for what they did to this company.

Company has no viable products, no revenue, incompetent, self-dealing management, multiple dilutions and reverse splits.

split

Look at all the reverse splits in this turd.

$BXRX fucking turds, two splits in one year, Good lord.

$BXRX  😂😂 and yet another split on the way,  what a horrific stock.

A 1 for 40 reverse stock split and an immediate dilution/stock offering……..in other words………a savage ass pounding without even a cigarette break.

stop

but this thang don’t stop tumbling down the mountain

Company doubled in size and reduced cash burn with no risk of dilution.

No risk of dilution and short interest has spiked, 500% increase.

Both went up over 100% after the r/s and before the capital raise.

No r/s risk and atm this year
$xela $muln $BBIG $SMMT

$BXRX two r/s in a year..🤦‍♂️🤦‍♂️

$BXRX performed RS just recently, dilution at its finest

news

$ENSC big news coming in days ahead,  very cheap.

Mid day top percent stock gainers on news and/or vol.

$INPX $BIAF $GROM $BXRX $COSM  very strong holding  above 1.90 that great news for tomorrow

We are the only low float good news stock today.

Analysts have set a price target of $3 for ENSC&#39;s stock, making it a strong buy for those looking to invest in the future of the industry🔥🚀 
 
Also following: 
$THMO $HUBC $TRKA $BXRX

$REVB More and More buys from all over the market are entering here now.

$INPX volume swelling on buys coming in locking it up
$BXRX go bulls!

🚨   $SPRC This could be the greatest buy in small caps right now or at least one of them.

Prty more up, cosm $4 buy spot,  Htgm filling premarket, slapping in 🔥

hold

$BXRX Long term hold for me PT 10 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀

.It will move on thin air 
$sidu is a nice hold 
$boxd nice volume.

$BXRX Once again bulls prove they can&#39;t hold shit

$BXRX as long as it holds the VWAP it is still bullish.

ReShape Lifesciences Inc.

short

$RSLS Straight fuckery with these shorts assholes

$RSLS shorts and naked shorts taking the piss again

$JFBR these greedy shorts deserve to get squeezed.

$RSLS oh boy $22 in next 5 minutes, shorts in trouble

They are bad anyway

 $NCMI $ANY and $NRBO lots of
Volume here 

 $RSLS sad what the shorts are
Doing

NEVER EVER HOLD A RUNNER OVER THE WEEKEND, HECK NEVER EVER HOLD A RUNNER OVERNIGHT NOT UNLESS YOU HAVE A CRYSTAL BALL AND I KNOW NO NONE DOES.

$RSLS Don’t hold this garbage I promise you you will regret it.

reversal

$RSLS retest of highs possible

$LUV southwest is dead.. Rip

$COSM holy ross rip my ass 
 
$BBBY $RSLS $KALA

company

$RSLS what ever happened to that kid who filed sec report after he bought 10% of the company over $5 Lol lmao
 wow the dump in this name has been nasty ….

Buyer beware, it’s not a good company, stop pretending like it is.

I realize that management of this company never think about shareholders as most of biotech companies do.

$RSLS The amount of time and effort you’re putting in bashing this company is highly suspicious.

It is still a money losing company that need to issue massive amounts of shares to keep paying incompetent management’s salaries.

$RSLS everyone do research on this company before you invest a dime it’s a scam be careful

COMPANY IS NOT REQUESTING TO WITHDRAW THE ABOVE REGISTRATION STATEMENT, MERELY THE TWO FORM RWs 
THAT WERE INCORRECTLY TAGGED.!!!

To be clear, the Company is not requesting to withdraw the above registration statement, merely the two Form RWs that were incorrectly tagged.

$RSLS they do when you are dealing with garbage companies! 😂💩💩🩸

No he has no reason to be ashamed of the current Biden economy; in a sea of red Sidus will still prove to be a winner and soon!

- PT 80$ (whoever)
- 6 months low for no reason! - Q4 best in company history (expected)

I like seeing people make money and there is no reason not to play other stocks / options on indexes- 
Buy write Puts / Calls on SPY / IWM / QQQ / AAPL /TSLA and daily trade these options.

but strong catalysts and progress with little to no dilution increase the odds of a much higher price of the stock.

Another one with FDA news like  r/s name, with good technical , reminds me of $RSLS $MSGM yesterday , which ran nice 7+ is the signal

After the dilution and R/S shorts are going to make MASSIVE profits.

profit

.glad I took my $49.80 profit when i did!!! !

They have hit the jackpot with their prediction on $BGXX and made a STAGGERING 17% PROFIT with ease.

$MGAM 
$RSLS
$LUCY
$TENX
$HILS thank for all the profits this week can&#39;t wait for next week buying my wife her stilettos for valentines day

$RSLS bringing some of my profits over to $BLPG 💯💯💯💯

BULLISH on volatility and trading locking in profits frequently.

Now i am calling $tcbp for a nice profit from these levels.

Now i am calling $GMVD for a nice profit from these levels.

bull

but I’m a bull and giving us opportunities to add n accumulate on the low volume dips ..

$RSLS nice bull pennant breakout, could test the days high soon

$RSLS 353k float let’s run it bulls 🚀🚀

$RSLS 27% up 5% down good job you fake punk ass bulls

volume

$INVO volume pick up $TENX and $RSLS ! !🚀🚀🚀🚀😆

$rsls nice pop

 $KALA 500,000 volume not bad

 $NVOS pulling back a bit 

 $MYO decent morning here

🚨Relative Volume Increase🚨 Part 1

$RSLS $PALT $LMFA $IFBD $SFIG 

Stay tuned for more ideas!

$RFL on the move  looknig great and strong a lot of room to run here   
golden cross is in 50ma vs 200ma = LONG (For the first time since October 2021)  
we need to breakout  2.41 and 2.51 for huge RUNUP   
low float volume is the key   
it was 66$ !!!

$RSLS nice formation, great, volume, strong rsi, and let’s not forget patent was approved

Cassava Sciences Inc

action

The day to day price action of this limp dick is more painful to watch than slugs breeding.

$SAVA , this daily one way action is depressing.

Zero confidence in management based on both recent actions and historical issues with the FDA. 2.

$SAVA We may get frustrated with volatility, manipulation, and irregular daily price action

price

This is sickening that these crooks can manipulate the price like this. !!!

He invites shorts to destroy stock price.. pathetic!

Some had to drop in price a little first!

new employee mr. cook must be pissed as this is lower price than the shares he got it for.

All.u did was dilute the pps 
..and release to prs to kill the stock price and momentum  
 You did so well..you fxuking scumbag.

I hate the stock price runup leading to an announcement.

data

- 
$AVXL in comparison, boring as hell - whenever Missling talks people fall asleep and holding back data and further readouts without any logical explanation are red flags -

$SAVA 
Pyggie here was bullish a few days ago, folded like a pussy because he can’t read data, and now spews FUD, like a spoiled child, because he’s worried he may have paper-handed a monster.

but offer only the “opinion” that there was “possible data manipulation.”

$SAVA longtime biotech investor and my honest experience when a CEO promises good data and there is a long waiting period = not good.

Sentiment matters in this game, and unfortunately, this company has been drug through the mud for so long that good data might just get overlooked.

$SAVA The ironic and sad thing is that this ticker has been abused and manipulated so badly that even if it triples on upcoming data release it still won&#39;t come close to ATH achieved on much less evidence of safety and efficacy.

The CEO belongs in jail with all this pump and dump stock manipulation and data manipulation

just annoying we all get so worked up and insulting when we, the retail investor, can neither move Remi to release data early or in truth, move the SP by buying or selling a few hundred shares.

$SAVA dumb management causing longs to lose confidence, you dont change the date of data release every few weeks, just give a date when you are certain and stick with that, its that simple

BIIB with a 27% chance of no decline - so bad, how can they even publish data like that.

patient

however, if you are a family member of Alz patient think about how fatiguing emotionally and financially it is to change diapers, have your name forgotten, or even have to take a license away from an otherwise healthy person.

but your day will come when you will pay back way more than the damage you have caused and the lives you have threatened from being treated for a debilitating disease.

$ALZN $ATHA $ORMP $SAVA $SPRC yes then go back to your scam board clown no need to trap others in this scam .. we know what value SAVA brings to their AD patients

Lecanemab approved - IV  infusion..increased infection risk, inconvenient for patients with MD&#39;s fully aware 
of side effects: brain swelling and bleeding. 2.

Eventually, the  
AD patient is unable to perform daily functions.

But the monoclonal antibody treatment also carries risks of brain swelling and bleeding.

$BIIB - lied and tried to push their bad drug Aduhelm on unsuspecting patients (one of which is a family member of mine).

3 deaths in 1900 trial patients.. how many deaths is our FDA going to inflict on millions of folks who are supposed to take this death drugs that also happen to have near-zero efficacy?? SMH

Avxl, not good they didn&#39;t have an agreement in place “plan for approval“ before they started the test fase 2b 500 patients.

$SAVA It&#39;s not only CRUEL for anyone to be prescribing any of these MABs for AD patients, it&#39;s impractical for both patients and the healthcare system in general.

application

$SAVA Words  to  to  ignorant,  never  hype  a  employee  from  fda,  shady  shiat! 🤡🤡🤡😂😂😂

It doesn&#39;t matter if drugs for terminal illnesses, have been approved after 6 months, because there is endless manipulation here, and this waiting game is based on either FDA approval or denial based on corruption at the agency?

This is such crap with the FDA my Father died a year ago from it

$BIIB $SAVA You would need uncommon patience to not be crazy mad at the system for this shenanigan approval process and decision from the FDA.

Idiots with no respect for integrity continues  to run 
wild within the FDA.

$SAVA once again we got fu*ked by the evil BIIB + FDA.

$SAVA THIS is how corrupt our FDA and state medical boards are.

$BIIB $SAVA  
I tell ya why - FDA is corrupt deep in its root, period!

have never read anyone who was negative about SAVA have a scientific reason for such.

This is one reason I am invested in Cassava.

YES, many reasons, so I believe a double down from here is highly likely !!

business-result

But the company actually has never seen before wonderful results.

And, make no mistake, the result are impressive.

It is the best results that have been seen in AD.

This could be huge in eliminating artificial FUD against the top-line results.

$SAVA Market is moving higher as SAVA is expecting data results.

Anavex is late like the sun comes up and still produces great results.

MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word &quot;Thrilled&quot; in Dec 6 PR.

Data tells me no safety issues, with a possible large therapeutic window.

Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated

$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.

but the data to date would predict continued efficacy that will be nigh on impossible to ignore.

$SAVA Institutional buying says data is good!! !

I’ll keep buying until data comes out…

Excited for the next data unveiling….bring it on!

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

This will bring in billions of revenue and it will make the life quality longer for AD patients.

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

CURING LEUKEMIA isn&#39;t a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

but mostly new hope for all the families and patients with AZ.

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

Top Stocks matching your search for "reasons dilution"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Mar, 20, 2023

Feb, 18, 2023

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Jan, 7, 2023

Nov, 7, 2022

BXRX

Baudax Bio Inc

-52.79%

$3.41 - $1.61

RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Mar, 20, 2023

Feb, 18, 2023

Feb, 12, 2023

Dec, 25, 2022

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Jan, 7, 2023

Nov, 7, 2022

Nov, 2, 2022

Oct, 6, 2022